TRO40303

DB16031InvestigationalSmall molecule

TRO40303 is under investigation in clinical trial NCT01374321 (Safety and Efficacy Study of TRO40303 for Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction).

Formula / weight: C₂₆H₄₇NO₂ · 405.667 g/mol (avg)
Code names: TRO-40303

Resolves to

Compound

UNII3W389841RNCAS14291-24-8ChEMBLCHEMBL4297500

Structure

InChIKeyOBKBVSFXEIFOMS-YVABUZGXSA-NSMILES[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC\C(=N/O)[C@](C)(CCCO)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)C

Targets

P30536TSPO

What you can answer from here — as of February 04, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with TRO40303, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account